期刊
TOXICOLOGY LETTERS
卷 190, 期 3, 页码 333-339出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.toxlet.2009.03.027
关键词
DNA adducts; Environmental genotoxins; Mutagenic threshold; Pharmaceutical impurities; Risk assessment; S(N)1 or S(N)2 reactions
类别
资金
- American Chemistry Council
- Brain Tumor Society
- Health Effects Institute
This perspective first considers the potential impact of the Viracept-EMS case in the framework of the current understanding of the low-dose effects of DNA-reactive chemicals and the approaches used to estimate health risks from genotoxins occurring as impurities in pharmaceutical products or as contaminants in the environment or workplace. It also presents an outlook on the nature of additional research building upon the Viracept-EMS case to test assumptions underlying thresholded dose-response relationships and to establish biologically based risk assessment models in lieu of default models for DNA-reactive compounds. (C) 2009 Published by Elsevier Ireland Ltd.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据